List of Tables
Table 1. Global Anticoagulant Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Anticoagulant Drugs Market Value by Clinical Indication (US$ Million), 2025 vs 2032
Table 3. Global Anticoagulant Drugs Market Value by Formulation Type (US$ Million), 2025 vs 2032
Table 4. Global Anticoagulant Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Anticoagulant Drugs Market Competitive Situation by Manufacturers in 2025
Table 6. Global Anticoagulant Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 7. Global Anticoagulant Drugs Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Anticoagulant Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Anticoagulant Drugs Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Anticoagulant Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Anticoagulant Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Anticoagulant Drugs, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Anticoagulant Drugs, Product Types and Applications
Table 14. Global Key Manufacturers of Anticoagulant Drugs, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Anticoagulant Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Anticoagulant Drugs Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Anticoagulant Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Anticoagulant Drugs Sales by Region (K Units), 2021–2026
Table 20. Global Anticoagulant Drugs Sales Market Share by Region (2021–2026)
Table 21. Global Anticoagulant Drugs Sales by Region (K Units), 2027–2032
Table 22. Global Anticoagulant Drugs Sales Market Share by Region (2027–2032)
Table 23. Global Anticoagulant Drugs Revenue by Region (US$ Million), 2021–2026
Table 24. Global Anticoagulant Drugs Revenue Market Share by Region (2021–2026)
Table 25. Global Anticoagulant Drugs Revenue by Region (US$ Million), 2027–2032
Table 26. Global Anticoagulant Drugs Revenue Market Share by Region (2027–2032)
Table 27. North America Anticoagulant Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Anticoagulant Drugs Sales by Country (K Units), 2021–2026
Table 29. North America Anticoagulant Drugs Sales by Country (K Units), 2027–2032
Table 30. North America Anticoagulant Drugs Revenue by Country (US$ Million), 2021–2026
Table 31. North America Anticoagulant Drugs Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Anticoagulant Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Anticoagulant Drugs Sales by Country (K Units), 2021–2026
Table 34. Europe Anticoagulant Drugs Sales by Country (K Units), 2027–2032
Table 35. Europe Anticoagulant Drugs Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Anticoagulant Drugs Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Anticoagulant Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Anticoagulant Drugs Sales by Region (K Units), 2021–2026
Table 39. Asia Pacific Anticoagulant Drugs Sales by Region (K Units), 2027–2032
Table 40. Asia Pacific Anticoagulant Drugs Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Anticoagulant Drugs Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Anticoagulant Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Anticoagulant Drugs Sales by Country (K Units), 2021–2026
Table 44. Latin America Anticoagulant Drugs Sales by Country (K Units), 2027–2032
Table 45. Latin America Anticoagulant Drugs Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Anticoagulant Drugs Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Anticoagulant Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Anticoagulant Drugs Sales by Country (K Units), 2021–2026
Table 49. Middle East and Africa Anticoagulant Drugs Sales by Country (K Units), 2027–2032
Table 50. Middle East and Africa Anticoagulant Drugs Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Anticoagulant Drugs Revenue by Country (US$ Million), 2027–2032
Table 52. Global Anticoagulant Drugs Sales (K Units) by Type (2021–2026)
Table 53. Global Anticoagulant Drugs Sales (K Units) by Type (2027–2032)
Table 54. Global Anticoagulant Drugs Sales Market Share by Type (2021–2026)
Table 55. Global Anticoagulant Drugs Sales Market Share by Type (2027–2032)
Table 56. Global Anticoagulant Drugs Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Anticoagulant Drugs Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Anticoagulant Drugs Revenue Market Share by Type (2021–2026)
Table 59. Global Anticoagulant Drugs Revenue Market Share by Type (2027–2032)
Table 60. Global Anticoagulant Drugs Price (US$/Unit) by Type (2021–2026)
Table 61. Global Anticoagulant Drugs Price (US$/Unit) by Type (2027–2032)
Table 62. Global Anticoagulant Drugs Sales (K Units) by Application (2021–2026)
Table 63. Global Anticoagulant Drugs Sales (K Units) by Application (2027–2032)
Table 64. Global Anticoagulant Drugs Sales Market Share by Application (2021–2026)
Table 65. Global Anticoagulant Drugs Sales Market Share by Application (2027–2032)
Table 66. Global Anticoagulant Drugs Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Anticoagulant Drugs Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Anticoagulant Drugs Revenue Market Share by Application (2021–2026)
Table 69. Global Anticoagulant Drugs Revenue Market Share by Application (2027–2032)
Table 70. Global Anticoagulant Drugs Price (US$/Unit) by Application (2021–2026)
Table 71. Global Anticoagulant Drugs Price (US$/Unit) by Application (2027–2032)
Table 72. Bristol-Myers Squibb Company Information
Table 73. Bristol-Myers Squibb Description and Business Overview
Table 74. Bristol-Myers Squibb Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. Bristol-Myers Squibb Anticoagulant Drugs Product
Table 76. Bristol-Myers Squibb Recent Developments/Updates
Table 77. Bayer Company Information
Table 78. Bayer Description and Business Overview
Table 79. Bayer Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 80. Bayer Anticoagulant Drugs Product
Table 81. Bayer Recent Developments/Updates
Table 82. Pfizer Company Information
Table 83. Pfizer Description and Business Overview
Table 84. Pfizer Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 85. Pfizer Anticoagulant Drugs Product
Table 86. Pfizer Recent Developments/Updates
Table 87. Johnson & Johnson Company Information
Table 88. Johnson & Johnson Description and Business Overview
Table 89. Johnson & Johnson Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 90. Johnson & Johnson Anticoagulant Drugs Product
Table 91. Johnson & Johnson Recent Developments/Updates
Table 92. Sanofi Company Information
Table 93. Sanofi Description and Business Overview
Table 94. Sanofi Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 95. Sanofi Anticoagulant Drugs Product
Table 96. Sanofi Recent Developments/Updates
Table 97. Boehringer Ingelheim Company Information
Table 98. Boehringer Ingelheim Description and Business Overview
Table 99. Boehringer Ingelheim Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 100. Boehringer Ingelheim Anticoagulant Drugs Product
Table 101. Boehringer Ingelheim Recent Developments/Updates
Table 102. Daiichi Sankyo Company Information
Table 103. Daiichi Sankyo Description and Business Overview
Table 104. Daiichi Sankyo Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 105. Daiichi Sankyo Anticoagulant Drugs Product
Table 106. Daiichi Sankyo Recent Developments/Updates
Table 107. Eisai Co Ltd Company Information
Table 108. Eisai Co Ltd Description and Business Overview
Table 109. Eisai Co Ltd Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 110. Eisai Co Ltd Anticoagulant Drugs Product
Table 111. Eisai Co Ltd Recent Developments/Updates
Table 112. Sun Pharmaceutical Company Information
Table 113. Sun Pharmaceutical Description and Business Overview
Table 114. Sun Pharmaceutical Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 115. Sun Pharmaceutical Anticoagulant Drugs Product
Table 116. Sun Pharmaceutical Recent Developments/Updates
Table 117. Teva Company Information
Table 118. Teva Description and Business Overview
Table 119. Teva Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 120. Teva Anticoagulant Drugs Product
Table 121. Teva Recent Developments/Updates
Table 122. Fresenius Company Information
Table 123. Fresenius Description and Business Overview
Table 124. Fresenius Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 125. Fresenius Anticoagulant Drugs Product
Table 126. Fresenius Recent Developments/Updates
Table 127. Jingzhou Pharma Company Information
Table 128. Jingzhou Pharma Description and Business Overview
Table 129. Jingzhou Pharma Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 130. Jingzhou Pharma Anticoagulant Drugs Product
Table 131. Jingzhou Pharma Recent Developments/Updates
Table 132. Changzhou Qianhong Company Information
Table 133. Changzhou Qianhong Description and Business Overview
Table 134. Changzhou Qianhong Anticoagulant Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 135. Changzhou Qianhong Anticoagulant Drugs Product
Table 136. Changzhou Qianhong Recent Developments/Updates
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Anticoagulant Drugs Distributors List
Table 140. Anticoagulant Drugs Customers List
Table 141. Anticoagulant Drugs Market Trends
Table 142. Anticoagulant Drugs Market Drivers
Table 143. Anticoagulant Drugs Market Challenges
Table 144. Anticoagulant Drugs Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
Table 148. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anticoagulant Drugs
Figure 2. Global Anticoagulant Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Anticoagulant Drugs Market Share by Type: 2025 & 2032
Figure 4. NOACs Product Picture
Figure 5. Heparin Product Picture
Figure 6. Warfarin Product Picture
Figure 7. Others Product Picture
Figure 8. Global Anticoagulant Drugs Market Value by Clinical Indication (US$ Million), 2021–2032
Figure 9. Global Anticoagulant Drugs Market Share by Clinical Indication: 2025 vs 2032
Figure 10. Atrial Fibrillation–Related Stroke Prevention Product Picture
Figure 11. Venous Thromboembolism Product Picture
Figure 12. Deep Vein Thrombosis Product Picture
Figure 13. Postoperative or Trauma-related Thrombosis Prevention Product Picture
Figure 14. Other Product Picture
Figure 15. Global Anticoagulant Drugs Market Value by Formulation Type (US$ Million), 2021–2032
Figure 16. Global Anticoagulant Drugs Market Share by Formulation Type: 2025 vs 2032
Figure 17. Oral Formulations Product Picture
Figure 18. Injectable Formulations Product Picture
Figure 19. Global Anticoagulant Drugs Market Value by Application (US$ Million), 2021–2032
Figure 20. Global Anticoagulant Drugs Market Share by Application: 2025 & 2032
Figure 21. Hospital
Figure 22. Pharmacy
Figure 23. Others
Figure 24. Global Anticoagulant Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 25. Global Anticoagulant Drugs Market Size (US$ Million), 2021–2032
Figure 26. Global Anticoagulant Drugs Sales (K Units), 2021–2032
Figure 27. Global Anticoagulant Drugs Average Price (US$/Unit), 2021–2032
Figure 28. Anticoagulant Drugs Report Years Considered
Figure 29. Anticoagulant Drugs Sales Share by Manufacturers in 2025
Figure 30. Global Anticoagulant Drugs Revenue Share by Manufacturers in 2025
Figure 31. Top 5 and Top 10 Global Anticoagulant Drugs Players: Market Share by Revenue in Anticoagulant Drugs in 2025
Figure 32. Anticoagulant Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 33. Global Anticoagulant Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 34. North America Anticoagulant Drugs Sales Market Share by Country (2021–2032)
Figure 35. North America Anticoagulant Drugs Revenue Market Share by Country (2021–2032)
Figure 36. U.S. Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Canada Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Europe Anticoagulant Drugs Sales Market Share by Country (2021–2032)
Figure 39. Europe Anticoagulant Drugs Revenue Market Share by Country (2021–2032)
Figure 40. Germany Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. France Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. U.K. Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Italy Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Russia Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Asia Pacific Anticoagulant Drugs Sales Market Share by Region (2021–2032)
Figure 46. Asia Pacific Anticoagulant Drugs Revenue Market Share by Region (2021–2032)
Figure 47. China Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Japan Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. South Korea Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. India Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Australia Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. China Taiwan Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Indonesia Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Thailand Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Malaysia Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Latin America Anticoagulant Drugs Sales Market Share by Country (2021–2032)
Figure 57. Latin America Anticoagulant Drugs Revenue Market Share by Country (2021–2032)
Figure 58. Mexico Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Brazil Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Argentina Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Middle East and Africa Anticoagulant Drugs Sales Market Share by Country (2021–2032)
Figure 62. Middle East and Africa Anticoagulant Drugs Revenue Market Share by Country (2021–2032)
Figure 63. Turkey Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 64. Saudi Arabia Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 65. UAE Anticoagulant Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 66. Global Sales Market Share of Anticoagulant Drugs by Type (2021–2032)
Figure 67. Global Revenue Market Share of Anticoagulant Drugs by Type (2021–2032)
Figure 68. Global Anticoagulant Drugs Price (US$/Unit) by Type (2021–2032)
Figure 69. Global Sales Market Share of Anticoagulant Drugs by Application (2021–2032)
Figure 70. Global Revenue Market Share of Anticoagulant Drugs by Application (2021–2032)
Figure 71. Global Anticoagulant Drugs Price (US$/Unit) by Application (2021–2032)
Figure 72. Anticoagulant Drugs Value Chain
Figure 73. Channels of Distribution (Direct Vs Distribution)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
